The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in the first of our Enforcement Webinars, which was held on May 3, 2011. This is a pilot program in which DDMAC gave our key stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by DDMAC in a given quarter. This particular webinar covered Warning Letters and Untitled Letters issued from January 2011 to April 2011.
Web address for viewing: https://collaboration.fda.gov/ddmac1/
For More Information:
Warning Letters and Notice of Violation Letters to Pharmaceutical Companies